会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Nonapeptide and decapeptide derivatives of luteinizing hormone releasing
hormone
    • 促黄体激素释放激素的非肽和十肽衍生物
    • US4234571A
    • 1980-11-18
    • US47661
    • 1979-06-11
    • John J. NestorGordon H. JonesBrian H. Vickery
    • John J. NestorGordon H. JonesBrian H. Vickery
    • A61K38/04A61K38/00A61K38/08A61K38/22A61P5/00C07K1/04C07K1/06C07K7/06C07K7/23C07K14/00C07K14/575A61K37/00C07C103/52
    • C07K7/23A61K38/00Y10S514/80Y10S930/12Y10S930/13
    • Nonapeptide and decapeptide analogs of LH-RH of the formula(pyro)Glu-His-V-Ser-W-X-Y-Arg-Pro-Z (I)and the pharmaceutically acceptable salts thereof wherein:V is tryptophyl, phenylalanyl or 3-(1-naphthyl)-L-alanyl;W is tyrosyl, phenylalanyl or 3-(1-pentafluorophenyl)-L-alanyl;X is a D-amino acid residue ##STR1## wherein R is (a) a carbocyclic aryl-containing radical selected from the group consisting of naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl, benzhydryl and phenyl substituted with three or more straight chain lower alkyl groups; or(b) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl and adamantyl;Y is leucyl, isoleucyl, nor-leucyl or N-methyl-leucyl;Z is glycinamide or --NH--R.sup.1, whereinR.sup.1 is lower alkyl, cycloalkyl, fluoro lower alkyl or ##STR2## wherein R.sup.2 is hydrogen or lower alkyl,are disclosed. These compounds exhibit potent LH-RH agonist properties.
    • 式(pyro)Glu-His-V-Ser-WXY-Arg-Pro-Z(I)的LH-RH的非肽和十肽类似物及其药学上可接受的盐,其中:V是色氨酸,苯丙氨酰或3-(1 - 萘基)-L-丙氨酰; W是酪氨酰基,苯丙氨酰基或3-(1-五氟苯基)-L-丙氨酰; X是D-氨基酸残基,其中R是(a)选自萘基,蒽基,芴基,菲基,联苯基,二苯甲基和被三个或更多个直链低级取代的苯基的含碳环芳基的基团 烷基; 或(b)选自由三个或更多个直链低级烷基取代的环己基,全氢萘基,全氢联苯基,全氢-2,2-二苯基甲基和金刚烷基的饱和碳环基团; Y是亮氨酰基,异亮氨酰基,正亮氨酰基或N-甲基 - 亮氨酰基; Z是甘氨酰胺或-NH-R 1,其中R 1是低级烷基,环烷基,氟低级烷基或其中R 2是氢或低级烷基。 这些化合物显示出有效的LH-RH激动剂性质。
    • 7. 发明授权
    • Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
    • LHRH的非肽和十肽类似物,可用作LHRH拮抗剂
    • US4419347A
    • 1983-12-06
    • US366635
    • 1982-04-08
    • John J. NestorGordon H. JonesBrian H. Vickery
    • John J. NestorGordon H. JonesBrian H. Vickery
    • A61K38/00C07K7/23A61K37/00C07C103/52
    • C07K7/23A61K38/00Y10S514/80Y10S930/13
    • Nonapeptide and decapeptide analogs of LHRH which have the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein: X is a D-alanyl residue wherein one hydrogen on C-3 is replaced by:(a) a carbocyclic aryl-containing radical selected from the group consisting of phenyl substituted with three or more straight chain lower alkyl groups, naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl and benzhydryl; or(b) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl, and adamantyl; or(c) a heterocyclic aryl containing radical selected from the group consisting of radicals represented by the following structural formulas: ##STR2## wherein A" and A' are independently selected from the group consisting of hydrogen, lower alkyl, chlorine, and bromine, and G is selected from the group consisting of oxygen, nitrogen, and sulfur;A is an aminoacyl residue selected from the group consisting of L-pyroglutamyl, D-pyroglutamyl, N-acyl-L-prolyl, N-acyl-D-prolyl, N-acyl-D-tryptophanyl, N-acyl-D-phenylalanyl, N-acyl-D-p-halophenylalanyl, and N-acyl-X wherein X is as defined previously;B is an amino acyl residue selected from the group consisting of D-phenylalanyl, D-p-halophenylalanyl, 2,2-diphenylglycyl, and X wherein X is as defined previously;C is an amino acyl residue selected from the group consisting of L-tryptophanyl, D-tryptophanyl, D-phenylalanyl and X wherein X is as defined above;E is glycinamide or --NH--R.sup.1, wherein R.sup.1 is lower alkyl, cycloalkyl, fluoro lower alkyl or ##STR3## wherein R.sup.2 is hydrogen or lower alkyl;are disclosed. These compounds are LHRH antagonists.
    • 具有式(I)的LHRH的非肽和十肽类似物及其药学上可接受的盐,其中:X是D-丙氨酰残基,其中C-3上的一个氢被:(a)碳环芳基 - 含有选自被三个或多个直链低级烷基取代的苯基的萘基,萘基,蒽基,芴基,菲基,联苯基和二苯甲基; 或(b)饱和碳环基团,其选自由三个或更多个直链低级烷基取代的环己基,全氢萘基,全氢联苯基,全氢-2,2-二苯基甲基和金刚烷基; 或(c)含有选自下列结构式的基团的杂环芳基基团:其中A“和A'独立地选自氢,低级 烷基,氯和溴,G选自氧,氮和硫; A是选自L-焦谷氨酰基,D-焦谷氨酰基,N-酰基-L-脯氨酰基,N-酰基-D-脯氨酰基,N-酰基-D-色氨酸基,N-酰基-D-苯丙氨酰基 ,N-酰基-Dp-卤代苯丙氨酰基和N-酰基-X,其中X如前所定义; B是选自D-苯丙氨酰,D-p-卤苯丙氨酰,2,2-二苯基甘氨酰和X的氨基酰基残基,其中X如前所定义; C是选自L-色氨酰基,D-色氨酸基,D-苯丙氨酰基和X的氨基酰基残基,其中X如上定义; E是甘氨酰胺或-NH-R 1,其中R 1是低级烷基,环烷基,氟低级烷基或者其中R 2是氢或低级烷基; 被披露。 这些化合物是LHRH拮抗剂。
    • 8. 发明授权
    • Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
    • LHRH的非肽和十肽类似物,可用作LHRH拮抗剂
    • US4341767A
    • 1982-07-27
    • US194180
    • 1980-10-06
    • John J. NestorGordon H. JonesBrian H. Vickery
    • John J. NestorGordon H. JonesBrian H. Vickery
    • A61K38/00C07K7/23A61K37/00C07C103/52
    • C07K7/23A61K38/00Y10S514/80Y10S930/13
    • Nonapeptide and decapeptide analogs of LHRH which have the formula: ##STR1## and the pharmaceutically acceptable salts thereof, wherein: X is a D-alanyl residue wherein one hydrogen on C-3 is replaced by:(a) a carbocyclic aryl-containing radical selected from the group consisting of phenyl substituted with three or more straight chain lower alkyl groups, naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl and benzhydryl; or(b) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl, and adamantyl; or(c) a heterocyclic aryl containing radical selected from the group consisting of radicals represented by the following structural formulas: ##STR2## wherein A" and A' are independently selected from the group consisting of hydrogen, lower alkyl, chlorine, and bromine, and G is selected from the group consisting of oxygen, nitrogen, and sulfur;A is an aminoacyl residue selected from the group consisting of L-pyroglutamyl, D-pyroglutamyl, N-acyl-L-prolyl, N-acyl-D-prolyl, N-acyl-D-tryptophanyl, N-acyl-D-phenylalanyl, N-acyl-D-p-halophenylalanyl, and N-acyl-X wherein X is as defined previously;B is an amino acyl residue selected from the group consisting of D-phenylalanyl, D-p-halophenylalanyl, 2,2-diphenylglycyl, and X wherein X is as defined previously;C is an amino acyl residue selected from the group consisting of L-tryptophanyl, D-tryptophanyl, D-phenylalanyl and X wherein X is as defined above;E is glycinamide or --NH--R.sup.1, wherein R.sup.1 is lower alkyl, cycloalkyl, fluoro lower alkyl or ##STR3## wherein R.sup.2 is hydrogen or lower alkyl; are disclosed. These compounds are LHRH antagonists.
    • 具有下式的LHRH的非肽和十肽类似物及其药学上可接受的盐,其中:X是D-丙氨酰残基,其中C-3上的一个氢被:(a)碳环芳基 选自由三个或更多个直链低级烷基取代的苯基的萘基,萘基,蒽基,芴基,菲基,联苯基和二苯甲基; 或(b)饱和碳环基团,其选自由三个或更多个直链低级烷基取代的环己基,全氢萘基,全氢联苯基,全氢-2,2-二苯基甲基和金刚烷基; 或(c)含有杂环芳基的基团,其选自由以下结构式表示的基团:其中A“和A'独立地选自氢 ,低级烷基,氯和溴,G选自氧,氮和硫; A是选自L-焦谷氨酰基,D-焦谷氨酰基,N-酰基-L-脯氨酰基,N-酰基-D-脯氨酰基,N-酰基-D-色氨酸基,N-酰基-D-苯丙氨酰基 ,N-酰基-Dp-卤代苯丙氨酰基和N-酰基-X,其中X如前所定义; B是选自D-苯丙氨酰,D-p-卤苯丙氨酰,2,2-二苯基甘氨酰和X的氨基酰基残基,其中X如前所定义; C是选自L-色氨酰基,D-色氨酸基,D-苯丙氨酰基和X的氨基酰基残基,其中X如上定义; E是甘氨酰胺或-NH-R 1,其中R 1是低级烷基,环烷基,氟低级烷基或者其中R 2是氢或低级烷基; 被披露。 这些化合物是LHRH拮抗剂。